EUVIMEDEUVIMED entdecken
Crossref

Topical Tranexamic Acid in Primary Breast Augmentation Surgery: Short- and Long-term Outcomes

Sarah Lonie, Gerald Marion Abesamis, Jenaleen Law, Mohammad Hassan Mohaghegh, Karen Vickery, Anand Deva, Kourosh Tavakoli

Aesthetic Surgery Journal · 2023

DOI: 10.1093/asj/sjad219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aesthetic Surgery Journal, 2023. Verfasst von Sarah Lonie und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Breast Implants, Tranexamic Acid, Mammaplasty, Contracture. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast augmentation mammaplasty (BAM) remains the most popular cosmetic procedure done worldwide. Bleeding in this procedure increases the chance of capsular contracture. Tranexamic acid (TXA), an antifibrinolytic, has been widely used by other surgical specialties to reduce bleeding.

Objectives

We aimed to evaluate the use of TXA in BAM surgery.

Methods

This was a single-surgeon case series of all patients who underwent primary BAM from March 2017 to March 2018 and received topical TXA spray to the implant pocket before implant insertion. Early postoperative complications and long-term outcomes, such as capsular contracture and revisional surgery, were recorded and described.

Results

Two hundred and eighty-eight patients were included in the study with an overall complication rate of 2.8% over 5 years. No patients had postoperative bleeding or hematoma formation. One patient had a seroma, managed with ultrasound drainage. Complications requiring reoperation included rippling (3, 1.0%), pocket revision (2, 0.7%), capsule contracture (1, 0.3%) and rupture (1, 0.3%).

Conclusions

This study highlights the safety and potential benefits of the use of topical TXA in breast augmentation, with low bleeding and capsular contracture rates. Level of Evidence: 4

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast ImplantsTranexamic AcidMammaplastyContractureBreast ImplantationFemaleHumansFollow-Up StudiesRetrospective Studies

Substanzen

Tranexamic Acid

Zitieren

APA

Lonie, S., Abesamis, G. M., Law, J., Mohaghegh, M. H., Vickery, K., Deva, A., & Tavakoli, K. (2023). Topical Tranexamic Acid in Primary Breast Augmentation Surgery: Short- and Long-term Outcomes. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjad219

Vancouver

Lonie S, Abesamis GM, Law J, Mohaghegh MH, Vickery K, Deva A, et al. Topical Tranexamic Acid in Primary Breast Augmentation Surgery: Short- and Long-term Outcomes. Aesthetic Surgery Journal. 2023. doi:10.1093/asj/sjad219

BibTeX
@article{Lonie2023,
  author = {Lonie, Sarah and Abesamis, Gerald Marion and Law, Jenaleen and Mohaghegh, Mohammad Hassan and Vickery, Karen and Deva, Anand and Tavakoli, Kourosh},
  title = {Topical Tranexamic Acid in Primary Breast Augmentation Surgery: Short- and Long-term Outcomes},
  journal = {Aesthetic Surgery Journal},
  year = {2023},
  doi = {10.1093/asj/sjad219}
}
Kostenlos starten →